Webinars

GPCRs are privileged drug targets. Approximately 100 receptors still escape from the drug discovery process as they are orphans, without…

A quantitative and robust bioassay that is reflective of the MOA of the drug is a critical component of any…

Regulation of immune responses is tightly controlled through a balance of co-stimulatory and inhibitory checkpoint receptors, which is often exploited…

Cell-based reporter gene assays are a well-established screening modality for developing drugs that target diverse signaling pathways.

COVID-19 has been declared a global pandemic by WHO. The disease is transmitted when the SARS-CoV-2 virus infects the respiratory…

The webinar focuses on utilizing an InCELL Pulse to characterize small-molecule cellular target engagement. As an example, a case study…

Throughout early discovery and particularly for market release, biologic drug candidates require mechanism-of-action (MOA)-based functional, cellular assays as characterisation tools…

Therapeutics targeting glucagon-like peptide, GLP-1 and GLP-2, receptors are being developed to address globally prevalent medical disorders for managing diabetes,…

The webinar addresses the challenge that much of the GPCR druggable space remains untapped for potential therapeutic targets. To address…

The webinar focusses on measuring antibody-mediated cell death using DiscoverX’s KILR Bioassays, and how they can be used to measure…

Bioassays are critical components of the quality control system for characterizing biologics. This roundtable involves an interactive panel discussion with…